The Current Ratio as of November 2024 (TTM) for Vigil Neuroscience, Inc. (VIGL) is 3.72

According to Vigil Neuroscience, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.72. This represents a change of -57.40% compared to the average of 8.74 of the last 4 quarters.

Vigil Neuroscience, Inc. (VIGL) Historical Current Ratio (quarterly & annually)

How has VIGL Current Ratio performed in the past?

The mean historical Current Ratio of Vigil Neuroscience, Inc. over the last ten years is 12.62. The current 3.72 Current Ratio has changed 2.85% with respect to the historical average. Over the past ten years (40 quarters), VIGL's Current Ratio was at its highest in in the March 2022 quarter at 25.83. The Current Ratio was at its lowest in in the September 2020 quarter at 0.

Vigil Neuroscience, Inc. (VIGL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Vigil Neuroscience, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vigil Neuroscience, Inc. (VIGL) Average Current Ratio

How has VIGL Current Ratio performed in the past?

The current Current Ratio of Vigil Neuroscience, Inc. (VIGL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Vigil Neuroscience, Inc. (VIGL) Current Ratio vs. Peers

How is VIGL’s Current Ratio compared to its peers?

Vigil Neuroscience, Inc.’s Current Ratio is less than Molecular Partners AG (14.33), less than PMV Pharmaceuticals, Inc. (13.98), less than Monte Rosa Therapeutics, Inc. (6.03), less than Entrada Therapeutics, Inc. (6.59), less than Third Harmonic Bio, Inc. (42.50), less than Cullinan Oncology, Inc. (24.46), less than Edgewise Therapeutics, Inc. (26.35), less than Rallybio Corporation (9.55), less than PepGen Inc. (8.47), less than Tyra Biosciences, Inc. (29.55), less than Compass Therapeutics, Inc. (40.74), greater than PureTech Health plc (3.68), greater than Opthea Limited (2.94), less than Pharvaris N.V. (19.08),

Build a custom stock screener for Vigil Neuroscience, Inc. (VIGL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vigil Neuroscience, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vigil Neuroscience, Inc. (VIGL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vigil Neuroscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.